| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | ATP8A1 IPO8 KCNT2 ATP13A1 TMEM94 SLC22A13 SLC2A7 SLC16A14 GRAMD1A SCN7A SLC5A9 HVCN1 TMC3 AQP6 ABCA9 | 1.03e-05 | 1289 | 64 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP8A1 IPO8 KCNT2 ATP13A1 TMEM94 SLC22A13 SLC2A7 SLC16A14 SCN7A SLC5A9 HVCN1 TMC3 AQP6 ABCA9 | 1.74e-05 | 1180 | 64 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.61e-05 | 109 | 64 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.65e-04 | 178 | 64 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 8.15e-04 | 477 | 64 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.04e-03 | 62 | 64 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 2.89e-03 | 25 | 64 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 2.89e-03 | 25 | 64 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 3.37e-03 | 27 | 64 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 3.42e-03 | 614 | 64 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 3.62e-03 | 28 | 64 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.70e-03 | 793 | 64 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 3.88e-03 | 29 | 64 | 2 | GO:0051119 | |
| HumanPheno | Rocker bottom foot | 3.41e-06 | 67 | 19 | 5 | HP:0001838 | |
| HumanPheno | Abnormal talus morphology | 4.25e-06 | 70 | 19 | 5 | HP:0008365 | |
| HumanPheno | Drug allergy | 3.95e-05 | 3 | 19 | 2 | HP:0410323 | |
| Domain | ARM-type_fold | 2.51e-07 | 339 | 65 | 10 | IPR016024 | |
| Domain | ARM-like | 4.26e-06 | 270 | 65 | 8 | IPR011989 | |
| Domain | TM_Fragile-X-F-assoc | 7.12e-05 | 4 | 65 | 2 | IPR019396 | |
| Domain | Tmemb_185A | 7.12e-05 | 4 | 65 | 2 | PF10269 | |
| Domain | - | 1.21e-04 | 222 | 65 | 6 | 1.25.10.10 | |
| Domain | APC_su10/DOC_dom | 2.48e-04 | 7 | 65 | 2 | IPR004939 | |
| Domain | DOC | 2.48e-04 | 7 | 65 | 2 | PS51284 | |
| Domain | APC10 | 2.48e-04 | 7 | 65 | 2 | SM01337 | |
| Domain | ANAPC10 | 2.48e-04 | 7 | 65 | 2 | PF03256 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.87e-04 | 37 | 65 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.87e-04 | 37 | 65 | 3 | PF00122 | |
| Domain | HEAT | 6.22e-04 | 48 | 65 | 3 | PF02985 | |
| Domain | HEAT | 1.08e-03 | 58 | 65 | 3 | IPR000357 | |
| Domain | RhoGAP | 1.31e-03 | 62 | 65 | 3 | SM00324 | |
| Domain | RhoGAP | 1.38e-03 | 63 | 65 | 3 | PF00620 | |
| Domain | IBN_N | 1.39e-03 | 16 | 65 | 2 | SM00913 | |
| Domain | RHOGAP | 1.44e-03 | 64 | 65 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 1.44e-03 | 64 | 65 | 3 | IPR000198 | |
| Domain | - | 1.44e-03 | 64 | 65 | 3 | 1.10.555.10 | |
| Domain | Importin-beta_N | 1.57e-03 | 17 | 65 | 2 | IPR001494 | |
| Domain | HEAT_REPEAT | 1.86e-03 | 70 | 65 | 3 | PS50077 | |
| Domain | Rho_GTPase_activation_prot | 3.58e-03 | 88 | 65 | 3 | IPR008936 | |
| Domain | - | 5.53e-03 | 32 | 65 | 2 | 3.40.1110.10 | |
| Domain | - | 5.53e-03 | 32 | 65 | 2 | 2.70.150.10 | |
| Domain | MFS | 6.33e-03 | 108 | 65 | 3 | PS50850 | |
| Domain | ATPase_P-typ_cyto_domN | 6.59e-03 | 35 | 65 | 2 | IPR023299 | |
| Domain | MFS_sugar_transport-like | 6.96e-03 | 36 | 65 | 2 | IPR005828 | |
| Domain | P_typ_ATPase | 6.96e-03 | 36 | 65 | 2 | IPR001757 | |
| Domain | Sugar_tr | 6.96e-03 | 36 | 65 | 2 | PF00083 | |
| Domain | ATPase_P-typ_P_site | 6.96e-03 | 36 | 65 | 2 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 6.96e-03 | 36 | 65 | 2 | PS00154 | |
| Domain | SAM_2 | 9.82e-03 | 43 | 65 | 2 | PF07647 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 20053912 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 35278713 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 12404111 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 24282028 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 29688337 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 30961637 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 5.82e-06 | 697 | 65 | 9 | 28298427 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 23230231 | ||
| Pubmed | Differential Intrasplenic Migration of Dendritic Cell Subsets Tailors Adaptive Immunity. | 1.03e-05 | 3 | 65 | 2 | 27545885 | |
| Pubmed | mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease. | 3.43e-05 | 5 | 65 | 2 | 32859226 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 19997493 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 15525354 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 29196450 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.07e-04 | 1105 | 65 | 9 | 35748872 | |
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 14697242 | ||
| Pubmed | 2.89e-04 | 169 | 65 | 4 | 31462741 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 4.16e-04 | 186 | 65 | 4 | 33637726 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 6.33e-04 | 208 | 65 | 4 | 33230847 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 6.79e-04 | 212 | 65 | 4 | 33853758 | |
| Pubmed | 7.76e-04 | 22 | 65 | 2 | 34905510 | ||
| Pubmed | 9.41e-04 | 402 | 65 | 5 | 24722188 | ||
| Pubmed | 1.26e-03 | 113 | 65 | 3 | 30352685 | ||
| Pubmed | Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8. | 1.26e-03 | 28 | 65 | 2 | 25752541 | |
| Pubmed | 1.35e-03 | 29 | 65 | 2 | 23565059 | ||
| Pubmed | 1.59e-03 | 916 | 65 | 7 | 32203420 | ||
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | 1.59e-03 | 453 | 65 | 5 | 27113764 | |
| Pubmed | 1.65e-03 | 32 | 65 | 2 | 31913463 | ||
| Pubmed | 1.68e-03 | 125 | 65 | 3 | 29467281 | ||
| Pubmed | 1.80e-03 | 128 | 65 | 3 | 30995482 | ||
| Interaction | TTYH1 interactions | 4.18e-06 | 300 | 63 | 8 | int:TTYH1 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.27e-04 | 50 | 43 | 3 | 721 | |
| Coexpression | GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN | 9.23e-06 | 199 | 64 | 6 | M8481 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.72e-09 | 184 | 65 | 7 | 2c286712428662bc4589dc5ac4011bf7ed403cb5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.75e-07 | 200 | 65 | 6 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.71e-06 | 168 | 65 | 5 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.99e-06 | 170 | 65 | 5 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.99e-06 | 170 | 65 | 5 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.99e-06 | 170 | 65 | 5 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.77e-06 | 181 | 65 | 5 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 185 | 65 | 5 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.57e-06 | 190 | 65 | 5 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.57e-06 | 190 | 65 | 5 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.57e-06 | 190 | 65 | 5 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-05 | 198 | 65 | 5 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.82e-05 | 137 | 65 | 4 | 2544d1256f11da6e3bad24a871b2253e0ab20d01 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.82e-05 | 137 | 65 | 4 | 874e2eaa7846a2832f46b77c726d79f220a4a1cd | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue-Cervical_normal_tissue|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.96e-05 | 138 | 65 | 4 | d3d16b043024914475a5e3db0803be0d4678c165 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue-Cervical_normal_tissue-5|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.96e-05 | 138 | 65 | 4 | d1efb4ef05aba89dd46ce698c5ce359fe8ab41c1 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.96e-05 | 138 | 65 | 4 | 3bb5d4c23335866d41e8e99db0676ee5799e5aff | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.96e-05 | 138 | 65 | 4 | c4f6381977d39ad3f7e1e1fa1217a802e8804132 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Gfra2_(Zona_Incerta,_ventral_part_(ZIV))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.70e-05 | 51 | 65 | 3 | 622a588dcf6f70c5e6b7133678c00fc68d70d6b5 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Gfra2_(Zona_Incerta,_ventral_part_(ZIV))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.70e-05 | 51 | 65 | 3 | 734b7ba494e57a0958999581c805eb90b9bbbd5a | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 7.04e-05 | 151 | 65 | 4 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 154 | 65 | 4 | a39877cdf7b441b5c953f744ed30f1d5acf4ea19 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.19e-05 | 157 | 65 | 4 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 160 | 65 | 4 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 160 | 65 | 4 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-05 | 162 | 65 | 4 | 15d5d31a75e26bcd41919a00300c68e9f00f0002 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.69e-05 | 164 | 65 | 4 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 166 | 65 | 4 | 21ba5fd755c0fb31ada42a1b5d60bede0153323d | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 1.06e-04 | 168 | 65 | 4 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 169 | 65 | 4 | 822e5b6c1e55e196e6d2a38bf183fd220c45703e | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 169 | 65 | 4 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 175 | 65 | 4 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-04 | 175 | 65 | 4 | 6751ee4b312d7f87275f2c35e5878cfc3be3ebe3 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 175 | 65 | 4 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-04 | 175 | 65 | 4 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-04 | 177 | 65 | 4 | f069197d39aacf7ad63be13133a6f3fd35d429ac | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 179 | 65 | 4 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-04 | 179 | 65 | 4 | 163f5430d72ea0c1b239ea5d21e53be536636d3d | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 179 | 65 | 4 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-04 | 179 | 65 | 4 | 0624dd537a68736f4d7b8b4de2c56168ed0e60a9 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.39e-04 | 180 | 65 | 4 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 180 | 65 | 4 | 852e0ea2da58605b059d533dc3fae368709e879a | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 1.42e-04 | 181 | 65 | 4 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | Control-Lymphoid-B|World / Disease state, Lineage and Cell class | 1.42e-04 | 181 | 65 | 4 | 9124f1a610cfc3355ad87921cd3eb5346956475d | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 1.42e-04 | 181 | 65 | 4 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 182 | 65 | 4 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 183 | 65 | 4 | 544939a0bfef082d361d88ef70d6f0923b8d9af9 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-04 | 183 | 65 | 4 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Control-Lymphoid-B|Control / Disease state, Lineage and Cell class | 1.51e-04 | 184 | 65 | 4 | de0294f879268bfd68e91adcc2adba211d221b7a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 8fa7aa2a954f66576ada56670b4e1bb122864761 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | b5fbfcf8516c2dc20dffc36803692505a63f1297 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 185 | 65 | 4 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 185 | 65 | 4 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 185 | 65 | 4 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 185 | 65 | 4 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 187 | 65 | 4 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 187 | 65 | 4 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.64e-04 | 188 | 65 | 4 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 188 | 65 | 4 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 188 | 65 | 4 | c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 188 | 65 | 4 | e82104f71bcdab7392fdb076dc3560255964fd9e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 1.67e-04 | 189 | 65 | 4 | f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 189 | 65 | 4 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 039b1922c85aa749d6578583d9d41a4eef8a6ac4 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 189 | 65 | 4 | 620d5a71b8cb6288540e2d2d848b9d4d66c1226f | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.67e-04 | 189 | 65 | 4 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 189 | 65 | 4 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 190 | 65 | 4 | bee6a438e217b2abd57aef2a80a9fe14a298d223 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 190 | 65 | 4 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | PCW_10-12-Immune_Lymphocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 190 | 65 | 4 | 9b56763d62e1ed50006a5b90b160c5a82aab515b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 191 | 65 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 191 | 65 | 4 | 9b8b64a36e27a2523b8730c7922fd7ad865a021e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 191 | 65 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 191 | 65 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 192 | 65 | 4 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 192 | 65 | 4 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 192 | 65 | 4 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 192 | 65 | 4 | 5995bae840c0b3f420288f557634d0ae9a12a6ae | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 192 | 65 | 4 | dee97f650ae6f4d07a142ade402aae1905791a22 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.78e-04 | 192 | 65 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Immune-natural_killer_cell|World / Lineage, Cell type, age group and donor | 1.78e-04 | 192 | 65 | 4 | 68121a6ef4115a93d87aad8802ef9b27d793d8c0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-04 | 192 | 65 | 4 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue | 1.78e-04 | 192 | 65 | 4 | f53426b9b1a63529307751c490a5a6214e499317 | |
| ToppCell | Endothelial-Endothelial-B|Endothelial / shred on cell class and cell subclass (v4) | 1.78e-04 | 192 | 65 | 4 | f8d7bd81e031d09a557722627c2f6180811cc6ab | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 193 | 65 | 4 | 8d88f3b0d08f9dbae26ee122dbd43f06e2cc3f67 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.81e-04 | 193 | 65 | 4 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 1.81e-04 | 193 | 65 | 4 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 193 | 65 | 4 | 00349d176fb6a46cbcc99c41d975651b6e9aaad4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.85e-04 | 194 | 65 | 4 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 194 | 65 | 4 | 7820c15ab987695a338462adb96a411df975b85b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 194 | 65 | 4 | 397619f3917a25fe4ae6772992ee7a3d8ad862e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 194 | 65 | 4 | 16eb26f4d1ac5ee6da74ebbce9fc2c0d54e9a693 | |
| ToppCell | B_cell_maturation-Naive_B_cell|B_cell_maturation / Lineage and Cell class | 1.85e-04 | 194 | 65 | 4 | adb6f9aff65276e0db1f8367149998938b8e4fb0 | |
| ToppCell | Control-Lymphoid|Control / Disease state, Lineage and Cell class | 1.85e-04 | 194 | 65 | 4 | d5b124f15c953eeb7e8e990df44d7fa466f2b31f | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 195 | 65 | 4 | 4570644bcf8bbdfcd70f3cd8840eb94d3df383c8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 195 | 65 | 4 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 195 | 65 | 4 | 36c784709ee32174e05b457500339c3b8eee3244 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | 3f065139f76ed048875cd6c03aa02300db2b6574 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 196 | 65 | 4 | 88dc4e3efd7ea07617ecde142ec47cc57608f81b | |
| Disease | gonadal dysgenesis (implicated_via_orthology) | 2.52e-05 | 4 | 61 | 2 | DOID:14447 (implicated_via_orthology) | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 7.03e-04 | 19 | 61 | 2 | EFO_0003100, GO_1902519 | |
| Disease | Hepatitis | 9.46e-04 | 22 | 61 | 2 | HP_0012115 | |
| Disease | cardiovascular age measurement | 1.65e-03 | 29 | 61 | 2 | EFO_0803380 | |
| Disease | complement factor H-related protein 2 measurement | 1.65e-03 | 29 | 61 | 2 | EFO_0600055 | |
| Disease | parental longevity | 3.55e-03 | 494 | 61 | 5 | EFO_0007796 | |
| Disease | household income | 3.63e-03 | 304 | 61 | 4 | EFO_0009695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NFCLSILASNILILV | 971 | O60241 | |
| EIIFIIQNLLIQILC | 1096 | Q8IUA7 | |
| LVVVAVNNQQLLCVL | 261 | Q8NHS2 | |
| LVIAQVLLLDFCLAL | 1171 | Q9HD20 | |
| TFIQIAQLLDLCILA | 271 | O96020 | |
| LVVALLVIFQVCLCQ | 11 | P32248 | |
| ELQLTNFCLLVDFLL | 466 | Q5JWR5 | |
| ILSAANIQIIFCDIL | 606 | Q008S8 | |
| NIQIIFCDILQILSL | 611 | Q008S8 | |
| FCDILQILSLNRQFL | 616 | Q008S8 | |
| GIQITSLLLVCILQF | 291 | Q6ZPD9 | |
| CVSLIILIALNVLLF | 616 | Q96CP6 | |
| ERITNVQILILFCIL | 291 | Q9Y2Q0 | |
| DNILQVLRIQLLQCV | 61 | Q6ZS30 | |
| LQIVIFLFLLLNCVL | 21 | A6NIJ9 | |
| CAQLVIAFILICIQL | 691 | P41594 | |
| ACLVLTVVLLFQNRV | 361 | Q6PXP3 | |
| FQVIIICLVVLDALL | 101 | Q96D96 | |
| RLAQLQQCLQAVLIF | 1241 | Q14999 | |
| LLLCFQVQVLVAEEN | 16 | O76093 | |
| QILCIQRAIQQKLVV | 1321 | Q6ZR08 | |
| LIILIIIFCLIEVNS | 916 | Q96QE4 | |
| KINQVLLFLLIVTLC | 6 | Q9H1C3 | |
| FNQVLILISTLLCLI | 196 | Q6UVM3 | |
| DLQTQILLFILFLII | 36 | Q8NGH3 | |
| AQLLALILELLTFCV | 541 | Q5MIZ7 | |
| NAILFCLLIEQALSQ | 1026 | Q96F07 | |
| LLQLTQVIDVCSNFL | 261 | Q9C0H6 | |
| LAQLRTLVFQCDLTL | 411 | Q52LW3 | |
| NLFVLLSVVCVLLNL | 6 | Q15884 | |
| LLEPLIIQVTTLVNC | 26 | Q9UI47 | |
| LGLNQEQFVDLCILL | 216 | P39748 | |
| CVQLQKQVLDLLAQL | 1441 | P42858 | |
| STQLNRILDLLFICV | 1321 | Q8NF50 | |
| AVELLLTLQLVLCVF | 146 | Q13520 | |
| QKLQNLFINFCLILI | 26 | P26678 | |
| RFQIQLLILLCVLNF | 16 | Q9Y226 | |
| VCAFIVLENLAVLLV | 46 | Q9H228 | |
| LQHICELFIITQLQS | 506 | O94955 | |
| QLENICLRIIDLVLQ | 631 | O15397 | |
| QCIPLFVQLVLERLT | 756 | O15397 | |
| VSLLIQFLIENCLRI | 536 | Q9P2F6 | |
| FIIRQLCLLLNAENI | 551 | Q08AM6 | |
| LQTLLCFLNDVVNLV | 786 | Q9Y3M8 | |
| FQQLLLCLVEVRALS | 416 | Q13285 | |
| NLAVTICLRIIANIL | 311 | Q7Z5M5 | |
| NQLICFEVIATLIIN | 511 | Q96DN5 | |
| QEVFFQAILLAVCLI | 231 | Q6P5X7 | |
| ELEILCSVNILQFIF | 141 | Q8NFB2 | |
| ELEILCSVNILQFIF | 141 | Q9H7F4 | |
| LFLLIQPCIRIIEQS | 486 | Q7RTX9 | |
| LNFILANIILSCIQP | 1386 | Q5K651 | |
| RCQIIIFQVVFLGLL | 801 | Q96CC6 | |
| CLLGISNEFIVLIEQ | 876 | O43166 | |
| SIQIQELCLNIIPTF | 461 | Q6P3W7 | |
| VCNINAVLLLAINIF | 661 | Q2M3M2 | |
| ICVIILLFILAVINL | 66 | Q16585 | |
| QLVRDVVLCSLLNFL | 106 | Q5VWP2 | |
| LLQLLVEPCQSQLFT | 501 | Q96M20 | |
| LVCVFLQSLIRNKII | 451 | Q9UKZ1 | |
| TLQILAELSCLQIFI | 1051 | Q96RL7 | |
| LLQCQLTLVVIQFLS | 1096 | Q12767 | |
| LTLVVIQFLSCLVQL | 1101 | Q12767 | |
| LEILCLLLNEQELQL | 251 | Q9HAV4 | |
| TCIVARNQLTFLLLL | 151 | Q9UH36 | |
| TLLLQLLQSCFSVLQ | 791 | O43149 | |
| LIICIILNVCFLTLE | 511 | Q01118 | |
| LEIFNQVVCALINLV | 56 | Q70CQ2 | |
| FLLINCSILIQIISH | 396 | Q9H3S5 | |
| CLELLENIFSLLLIT | 571 | Q68DK2 |